nifekalant hydrochloride has been researched along with azimilide in 1 studies
| Studies (nifekalant hydrochloride) | Trials (nifekalant hydrochloride) | Recent Studies (post-2010) (nifekalant hydrochloride) | Studies (azimilide) | Trials (azimilide) | Recent Studies (post-2010) (azimilide) |
|---|---|---|---|---|---|
| 138 | 16 | 38 | 141 | 27 | 6 |
| Protein | Taxonomy | nifekalant hydrochloride (IC50) | azimilide (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Cavia porcellus (domestic guinea pig) | 0.18 | |
| Potassium voltage-gated channel subfamily KQT member 1 | Cavia porcellus (domestic guinea pig) | 0.24 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.9032 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furutani, K; Inanobe, A; Iwata, M; Kurachi, Y; Ohno, Y; Yamakawa, Y | 1 |
1 other study(ies) available for nifekalant hydrochloride and azimilide
| Article | Year |
|---|---|
A mechanism underlying compound-induced voltage shift in the current activation of hERG by antiarrhythmic agents.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Hydantoins; Imidazolidines; Membrane Potentials; Piperazines; Pyrimidinones; Xenopus laevis | 2011 |